These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22811539)

  • 1. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions.
    J Reddy PB; Schreiber TH; Rajasagi NK; Suryawanshi A; Mulik S; Veiga-Parga T; Niki T; Hirashima M; Podack ER; Rouse BT
    J Virol; 2012 Oct; 86(19):10606-20. PubMed ID: 22811539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azacytidine Treatment Inhibits the Progression of Herpes Stromal Keratitis by Enhancing Regulatory T Cell Function.
    Varanasi SK; Reddy PBJ; Bhela S; Jaggi U; Gimenez F; Rouse BT
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions.
    Sehrawat S; Suvas S; Sarangi PP; Suryawanshi A; Rouse BT
    J Virol; 2008 Jul; 82(14):6838-51. PubMed ID: 18480441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.
    Sehrawat S; Suryawanshi A; Hirashima M; Rouse BT
    J Immunol; 2009 Mar; 182(5):3191-201. PubMed ID: 19234217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling.
    Veiga-Parga T; Suryawanshi A; Rouse BT
    PLoS Pathog; 2011 Dec; 7(12):e1002427. PubMed ID: 22174686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling Herpes Simplex Virus-Induced Immunoinflammatory Lesions Using Metabolic Therapy: a Comparison of 2-Deoxy-d-Glucose with Metformin.
    Berber E; Rouse BT
    J Virol; 2022 Jul; 96(14):e0068822. PubMed ID: 35862706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen.
    Rowe AM; Yun H; Treat BR; Kinchington PR; Hendricks RL
    J Immunol; 2017 Feb; 198(4):1706-1717. PubMed ID: 28062697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.
    Sarangi PP; Kim B; Rouse BT
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5425-33. PubMed ID: 18689698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.
    Sehrawat S; Reddy PB; Rajasagi N; Suryawanshi A; Hirashima M; Rouse BT
    PLoS Pathog; 2010 May; 6(5):e1000882. PubMed ID: 20463811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic expansion of CD4(+) T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology.
    Suvas S; Kim B; Rouse BT
    Microbes Infect; 2008; 10(10-11):1192-200. PubMed ID: 18657630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection.
    Buela KA; Hendricks RL
    J Immunol; 2015 Jan; 194(1):379-87. PubMed ID: 25422507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
    Gangappa S; Deshpande SP; Rouse BT
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementing the Diet with Sodium Propionate Suppresses the Severity of Viral Immuno-inflammatory Lesions.
    Sumbria D; Berber E; Rouse BT
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33208449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A crucial role for B and T lymphocyte attenuator in preventing the development of CD4+ T cell-mediated herpetic stromal keratitis.
    Xia L; Zhang S; Zhou J; Li Y
    Mol Vis; 2010 Oct; 16():2071-83. PubMed ID: 21042564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis.
    Banerjee K; Biswas PS; Rouse BT
    J Leukoc Biol; 2005 Jan; 77(1):24-32. PubMed ID: 15496448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibody.
    Krawczyk A; Dirks M; Kasper M; Buch A; Dittmer U; Giebel B; Wildschütz L; Busch M; Goergens A; Schneweis KE; Eis-Hübinger AM; Sodeik B; Heiligenhaus A; Roggendorf M; Bauer D
    PLoS One; 2015; 10(1):e0116800. PubMed ID: 25587898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.
    Jiang Y; Yin X; Stuart PM; Leib DA
    mBio; 2015 Oct; 6(6):e01426-15. PubMed ID: 26507231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses.
    Kim B; Sarangi PP; Azkur AK; Kaistha SD; Rouse BT
    Microbes Infect; 2008 Mar; 10(3):302-12. PubMed ID: 18325811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition.
    Gangappa S; Babu JS; Thomas J; Daheshia M; Rouse BT
    J Immunol; 1998 Oct; 161(8):4289-300. PubMed ID: 9780205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of IL-27 signaling ameliorates herpes stromal keratitis with upregulated CD4
    Xia L; Tan T; Li Y; Zhong Q; Shi M
    Indian J Ophthalmol; 2019 Nov; 67(11):1821-1828. PubMed ID: 31638041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.